The aim of our work was to investigate the underlying mechanism of PTEN in the maintenance of CIN and to evaluate the potential of PARP1 inhibitor treatment in TNBC with high CIN. This evidence concerns the gene PTEN and cervical squamous intraepithelial neoplasia.